[ad_1]
Innovative treatment with Enfortumab for the metastatic urothelial cancer cancer network
A new agent targeting nectin 4, a protein found in 97% of urothelial cancers, could be an option for patients with locally advanced or metastatic forms of cancer.
[ad_2]Source link
